As of 2025-09-16, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -10.17 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.41 USD, the upside of Cogent Biosciences Inc is -181.93%.
Based on its market price of 12.41 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 181.93%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.17 - -10.17 | -10.17 | -181.93% |
| P/E | (34.08) - (41.85) | (40.31) | -424.8% |
| DDM - Stable | (17.53) - (67.21) | (42.37) | -441.4% |
| DDM - Multi | (3.38) - (10.22) | (5.09) | -141.1% |
| Market Cap (mil) | 1,733.68 |
| Beta | 1.23 |
| Outstanding shares (mil) | 139.70 |
| Enterprise Value (mil) | 1,650.03 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.42% |
| Cost of Debt | 5.00% |
| WACC | 6.55% |